Archive for the ‘research’ Category

They Shall Not Be Left to Rot: The Emerging Law of Lyme Disease

https://www.belmontlawreview.org/articles/volume-8-issue-1-2020/

transparent-law-logo-retina

VOLUME 8, ISSUE 1: 2020

Creighton R. Meland, Jr.

They Shall Not Be Left to Rot: The Emerging Law of Lyme Disease

For the excellently written paper for the Belmont Law Review, on the state of affairs with Lyme disease, please see this pdf:  https://cpb-us-w2.wpmucdn.com/blogs.belmont.edu/dist/8/25/files/2020/11/Meland_95-163.pdf

Table of Contents:

INTRODUCTION 96

I. WHAT IS LYME DISEASE AND WHY IS IT MEDICALLY CONTROVERSIAL? 97

     A. What is Lyme Disease? 97

     B. Lyme Disease Detection and Diagnosis 101

     C. Lyme Disease Treatment Regimens 104

          1. IDSA v. ILADS 104

          2. Coinfections and their Effect on Treatment 106

     D. Lyme Disease is not a Research Priority 107

II. LYME DISEASE LEGAL ISSUES 108

     A. IDSA and CDC Set Treatment Standards 108

          1. Effects on Quality and Availability of Care 108

          2. Antitrust Implications 112

     B. State Lyme Disease Legislation 122

          1. Health Insurance Coverage Mandates 122

          2. Professional Standards 125

          3. Lyme Testing Disclosures 127

          4. Safe Harbors 130

          5. Awareness, Prevention, and Government Support 133

**J.D. University of Michigan; B.S. Economics, Major in Finance, Wharton School, Undergraduate Division, University of Pennsylvania.**

I am grateful to Belmont Law Review for the opportunity to critique laws designed to redress health care problems presented by Lyme disease. Despite a pervasive presence and severe symptoms, Lyme disease is widely misunderstood by the medical community and too often goes untreated or improperly treated. While we await advances in medical science, the law can help those who suffer. I recognize and thank the International Lyme and Associated Diseases Society and its many contributors, who have deepened my understanding of medical problems associated with Lyme disease.  These insights have influenced positively the form of the work I now submit.

Mushroom Power: Five Therapeutic Properties of Medicinal Mushrooms

https://www.greenmedinfo.com/blog/mushroom-power-five-therapeutic-properties-medicinal-mushrooms1?

Mushroom Power: Five Therapeutic Properties of Medicinal Mushrooms

© 4/22/21] GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here:  //www.greenmedinfo.com/greenmed/newsletter.

Mushrooms have recently gained popularity in culinary circles, but their far-reaching therapeutic properties should get your attention for a longer and healthier life

Although mushrooms have been part of the healer’s toolbox since ancient times, the medicinal power of mushrooms is gaining momentum in evidence-based journals.

Medicinal mushrooms come in a wide variety and shapes such as white button, reishi, maitake, shiitake, oyster, cordyceps, cauliflower, tiger tail and lion’s mane, and most have health benefits that range from fighting cancer and boosting your immunity and memory to preventing diseases like diabetes and arthritis.

Five Therapeutic Properties of Mushrooms

1. Anticancer

Reishi (in Japanese) or lingzhi (in Chinese) mushrooms are well known in Asia for their anticancer properties. In a meta-analysis by scientists of 23 trials involving 4,246 cancer patients, reishi mushrooms enhanced longevity and quality of life in cancer patients.[i]

Therapy with white button mushrooms impacted prostate-specific antigen (PSA) levels and inhibited prostate cancer by decreasing immunosuppressive factors.[ii]

Polysaccharides from Cordyceps cicadae mushrooms inhibited the growth of cancer cells and induced cancer cell deaths showing its effectiveness as a low cost and safe treatment for cervical cancer.[iii]

A peptide from the shiitake mushroom showed promising results in growth arrest, cell death and cleaning out damaged cells in a breast cancer in vitro study.[iv] In both in vitro and in vivo studies, results showed that mice with induced testicular cancer treated with the Cordyceps sinensis mushroom had significantly smaller and fewer tumors than the control group.[v]

Cordyceps cicadae mushroom treatment prevented testicular damage and tumors caused by the chemotherapy drug cisplatin via inhibition of oxidative stress and inflammation in rats.[vi]

In a lung cancer-induced study of mice, treatment with reishi mushrooms inhibited cell viability and mobility of lung cancer cells in vitro.[vii] In a cell study of reishi mushroom extract, the treatment offered high antitumor and liver protection with low toxicity on human liver cancer cells.[viii]

2. Immunomodulatory

In a meta-analysis of 20 animal disease studies, grifola frondosa, or maitake mushroom, polysaccharide showed strong immune function by enhancing T cells, natural killer cells and macrophages in mice and increasing the secretion of two important immune factors, TNF-α and INF-γ.[ix]

In a clinical study of 105 cancer patients undergoing chemotherapy or radiation treatments, a combination of reishi mushroom extract and geraniums improved immunity and fought the cancer and secondary infections that could have compromised treatment and health.[x]

In a study of 18 patients diagnosed with low and intermediate myelodysplastic syndrome, which can lead to leukemia if not managed well, maitake mushroom extract treatment of three milligrams (mg) twice a day for 12 weeks increased immunity, positively affecting neutrophil, monocyte and free radical production.[xi]

In a clinical study of asymptomatic children from 3 to 5 years old, treatment with beta glucans from reishi mushrooms showed increased immune system cells in the peripheral blood — signaling a strong defense against childhood infections.[xii]

Reviewing in vivo and in vitro studies on mice and human cell lines using lion’s mane (Hericium erinaceus) and tiger tail (Trametes versicolor) mushrooms, treatments showed immunomodulatory, anticancer, anti-inflammatory and neuroregenerative effects.[xiii]

3. Antioxidant

Polysaccharide beta glucan extracted from reishi mushroom was shown to be a powerful antioxidant in 37 high risk and 34 stable angina patients; those who were treated with 750 mg per day for three months had significantly decreased oxidative radicals and improved progression of atherosclerosis.[xiv]

In a study of 42 healthy subjects, another intervention with beta glucan from reishi mushrooms of 225 mg per day for three months demonstrated its antioxidative effects — enhanced total antioxidant capacity and enzyme activities as well as reduced mild fatty liver condition to normal by suppressing oxidative stress were observed.[xv]

4. Anti-inflammatory 

Crohn’s disease is a chronic inflammatory disease of the gastrointestinal tract. Treatment with a triterpene compound from reishi mushrooms showed that the inflammatory cytokines were significantly inhibited in a study of children with Crohn’s disease.[xvi]

Sixty patients with moderate persistent asthma were studied and those who took the cordyceps sinensis mushroom capsule for two months had reduced airway inflammation caused by their chronic asthma.[xvii]Cordycepin from medicinal mushrooms showed strong effects on many anti-inflammatory diseases.[xviii]

In a study of 32 patients with active rheumatoid arthritis, supplementation of medicinal mushroom and Chinese herbs — reishi (4 grams) and San Miao San (2.4 grams) daily — lowered arthritic pain for patients.[xix] The data in a mice study support a model where white button mushrooms regulate immunity in vitro and protect the colon from inflammation-induced injuries in vivo.[xx]

The brain is susceptible to inflammation as well. In an Alzheimer’s disease model of rats, treatment with medicinal mushroom extracts delayed disease progression, improved learning and memory functions and stopped neural cell deaths and brain atrophy.[xxi]

Chaga mushrooms administered to mice successfully protected against Alzheimer’s disease by modulating oxidative stress, Nrf2 signaling and mitochondrial cell deaths while improving memory and cognition.[xxii]Cordycepin from the Cordyceps sinensis mushroom alleviated Parkinson’s disease motor disorder symptoms by lowering oxidative stress and inflammation in vivo and in vitro.[xxiii]

Lion’s mane mushrooms were supplemented for 12 weeks and were effective in preventing dementia and cognitive decline.[xxiv] Lion’s mane supplementation for four weeks in a study of 30 females also reduced depression and anxiety.[xxv]

5. Antidiabetic

Dyslipidemia, high blood cholesterol and triglycerides is often a harbinger of future diabetes. In a rat model, white button mushrooms and a probiotic were found to lower dyslipidemia and decrease oxidative stress.[xxvi] In a study of 89 diabetic patients, oyster mushroom consumption significantly reduced blood glucose, blood pressure, triglycerides and cholesterol without ill effects on the liver or kidneys.[xxvii]

Polyphenols from Phellinus igniarius, or willow bracket, mushroom extract were used in vitro and in vivo studies of induced Type 2 diabetes mice and showed improved glucose tolerance, reduced hyperglycemia and normalized insulin levels.[xxviii]

Diabetic nephropathy, kidney disease caused by Type 2 diabetes, was studied in vitro with disease-induced rats and treatment with Cordyceps cicadae resulted in improved insulin resistance and glucose tolerance, suppressed inflammation and balanced gut microbiome thus stopping the diabetes-related progression of renal disease and tumors.[xxix]

In an animal study, maitake mushroom prevented the progression of kidney fibrosis in diabetic nephropathy rats, significantly decreased fasting blood glucose levels, reduced inflammatory cytokines and lowered renal fibrosis indexes indicating its effectiveness in the treatment or prevention of nephropathy.[xxx]

In their meta-analysis of 623 articles and 33 randomized controlled experiments using cauliflower mushroom extract (S. Crispa), researchers found statistically significant differences in diabetic symptoms including decreased serum insulin levels and wound rates and an increase in nutrient intake content.[xxxi]

Mushrooms and Their Medicinal Powers

Medicinal mushrooms are widely researched and used as treatment in the prevention and progression of many diseases from cancer and asthma to diabetes and dementia. Mushrooms protect you due to their anti-inflammatory, antitumor, antidiabetic, immune boosting and antioxidant activities. To learn more, see GreenMedInfo.com’s database on mushrooms.


References

[i] Zhong L, Yan P, Lam WC, Yao L, Bian Z. Coriolus Versicolor and Ganoderma Lucidum Related Natural Products as an Adjunct Therapy for Cancers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol. 2019 Jul 3;10:703. doi: 10.3389/fphar.2019.00703. PMID: 31333449; PMCID: PMC6616310.

[ii] Przemyslaw Twardowski, Noriko Kanaya, Paul Frankel, Timothy Synold, Christopher Ruel, Sumanta K Pal, Maribel Junqueira, Manisha Prajapati, Tina Moore, Pamela Tryon, Shiuan Chen. A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses. Cancer. 2015 Sep 1 ;121(17):2942-50. Epub 2015 May 18. PMID: 25989179

[iii] Jiao Xu, Zhi-Cheng Tan, Zhong-Yuan Shen, Xing-Jia Shen, Shun-Ming Tang. Cordyceps cicadae polysaccharides inhibit Human cervical cancer Hela cells proliferation via Apoptosis and Cell Cycle Arrest. Food Chem Toxicol. 2021 Jan 6:111971. Epub 2021 Jan 6. PMID: 33421460

[iv] Syed Riaz Ud Din, Mintao Zhong, Muhammad Azhar Nisar, Muhammad Zubair Saleem, Akbar Hussain, Kavish H Khinsar, Shahid Alam, Gohar Ayub, Sadia Kanwal, Xingyun Li, Wei Zhang, Xiaoli Wang, Anhong Ning, Jing Cao, Min Huang. Latcripin-7A, derivative of Lentinula edodes C, reduces migration and induces apoptosis, autophagy, and cell cycle arrest at Gphase in breast cancer cells. Appl Microbiol Biotechnol. 2020 Dec ;104(23):10165-10179. Epub 2020 Oct 12. PMID: 33044599

[v] Ming-Min Chang, Siou-Ying Hong, Shang-Hsun Yang, Chia-Ching Wu, Chia-Yih Wang, Bu-Miin Huang. Anti-Cancer Effect of Cordycepin on FGF9-Induced Testicular Tumorigenesis. Int J Mol Sci. 2020 Nov 6 ;21(21). Epub 2020 Nov 6. PMID: 33172093

[vi] Ling Wang, Yigang He, Yudi Li, Chengbin Pei, Opeyemi Joshua Olatunji, Jian Tang, Ademola C Famurewa, Hongyan Wang, Bei Yan. Protective Effects of Nucleosides-Rich Extract from Cordyceps cicadae against Cisplatin Induced Testicular Damage. Chem Biodivers. 2020 Nov ;17(11):e2000671. Epub 2020 Nov 3. PMID: 33007148

[vii] Wei-Hung Hsu, Wei-Lun Qiu, Shu-Ming Tsao, Ai-Jung Tseng, Mei-Kuang Lu, Wei-Jyun Hua, Hsin-Chung Cheng, Hsien-Yeh Hsu, Tung-Yi Lin. Effects of WSG, a polysaccharide from Ganoderma lucidum, on suppressing cell growth and mobility of lung cancer. Int J Biol Macromol. 2020 Oct 1. Epub 2020 Oct 1. PMID: 33011264

[viii] Liping Zhu, Min Wu, Peng Li, Yanfei Zhou, Jinyi Zhong, Zhiqiang Zhang, Ye Li, Weixi Yao, Jianhua Xu. High-Pressure Supercritical COExtracts ofFruiting Body and Their Anti-hepatoma Effect Associated With the Ras/Raf/MEK/ERK Signaling Pathway. Front Pharmacol. 2020 ;11:602702. Epub 2020 Dec 14. PMID: 33381043

[ix] Zhang T, Zhao F, Wu KN, Jia Y, Liao XL, Yang FW, Zhang JH, Ma B. Meta-analysis on effect of Grifola frondosa polysaccharide in regulating in vivo immunoregulatory function on animal disease models. Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(23):5174-5183. Chinese. doi: 10.19540/j.cnki.cjcmm.20190823.401. PMID: 32237355.

[x] Zhuang SR, Chen SL, Tsai JH, Huang CC, Wu TC, Liu WS, Tseng HC, Lee HS, Huang MC, Shane GT, Yang CH, Shen YC, Yan YY, Wang CK. Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy. Phytother Res. 2009 Jun;23(6):785-90. doi: 10.1002/ptr.2623. PMID: 19145638.

[xi] Wesa KM, Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother. 2015 Feb;64(2):237-47. doi: 10.1007/s00262-014-1628-6. Epub 2014 Oct 29. PMID: 25351719; PMCID: PMC4317517

[xii] Sandra Lorena Duque Henao, Sergio A Urrego, Andrea M Cano, Edwin A Higuita. Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched withβ-Glucans from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Children from Medellin, Colombia. Int J Med Mushrooms. 2018 ;20(8):705-716. PMID: 30317947

[xiii] Mateusz Winder, Weronika Bulska-Będkowska, Jerzy Chudek. The use of Hericium erinaceus and Trametes versicolor extracts in supportive treatment in oncology. Acta Pharm. 2021 Mar 1 ;71(1):1-16. PMID: 32697746

[xiv] Djanggan Sargowo, Nadia Ovianti, Eliana Susilowati, Nizamuddin Ubaidillah, Adriyawan Widya Nugraha, Vitriyaturrida, Kartika Siwi Proboretno, Mirza Failasufi, Fadhli Ramadhan, Hesti Wulandari, Yoga Waranugraha, Dinarsari Hayuning Putri. The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients. Indian Heart J. 2018 Sep – Oct;70(5):608-614. Epub 2017 Dec 14. PMID: 30392496

[xv] Hui-Fang Chiu, Hui-Yu Fu, Yan-Ying Lu, Yi-Chun Han, You-Cheng Shen, Kamesh Venkatakrishnan, Oksana Golovinskaia, Chin-Kun Wang. Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers. Pharm Biol. 2017 Dec ;55(1):1041-1046. PMID: 28183232

[xvi] Changda Liu, David Dunkin, Joanne Lai, Ying Song, Clare Ceballos, Keith Benkov, Xiu-Min Li. Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn’s Disease Associated with Downregulation of NF-κB Signaling. Inflamm Bowel Dis. 2015 May 19. Epub 2015 May 19. PMID: 25993687

[xvii] Ning-qun Wang, Liang-duo Jiang, Xiao-mei Zhang, Zong-xin Li. Effect of dongchong xiacao capsule on airway inflammation of asthmatic patients. J Hypertens. 2005 Sep;23(9):1699-706. PMID: 17972591

[xviii] Tan L, Song X, Ren Y, Wang M, Guo C, Guo D, Gu Y, Li Y, Cao Z, Deng Y. Anti-inflammatory effects of cordycepin: A review. Phytother Res. 2020 Oct 8. doi: 10.1002/ptr.6890. Epub ahead of print. PMID: 33090621.

[xix] Edmund K Li, Lai-Shan Tam, Chun Kwok Wong, Wai Ching Li, Christopher W K Lam, Sissi Wachtel-Galor, Iris F Benzie, Yi Xi Bao, Ping Chung Leung, Brian Tomlinson. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):208-11. PMID: 17907228

[xx] Sanhong Yu, Veronika Weaver, Keith Martin, Margherita T Cantorna. The effects of whole mushrooms during inflammation. BMC Immunol. 2009;10:12. Epub 2009 Feb 20. PMID: 19232107

[xxi] Guoxiao Lai, Yinrui Guo, Diling Chen, Xiaocui Tang, Ou Shuai, Tianqiao Yong, Dongdong Wang, Chun Xiao, Gailian Zhou, Yizhen Xie, Burton B Yang, Qingping Wu. Alcohol Extracts FromDelay the Progress of Alzheimer’s Disease by Regulating DNA Methylation in Rodents. Front Pharmacol. 2019 ;10:272. Epub 2019 Mar 26. PMID: 30971923

[xxii] Yanqiu Han, Shanji Nan, Jia Fan, Qiuhui Chen, Yizhi Zhang. Inonotus obliquus polysaccharides protect against Alzheimer’s disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects. Int J Biol Macromol. 2019 Mar 13 ;131:769-778. Epub 2019 Mar 13. PMID: 30878614

[xxiii] Chunyan Cheng, Xiaoying Zhu. Cordycepin mitigates MPTP-induced Parkinson’s disease through inhibiting TLR/NF-κB signaling pathway. Life Sci. 2019 Feb 18. Epub 2019 Feb 18. PMID: 30790609

[xxiv] Yuusuke Saitsu, Akemi Nishide, Kenji Kikushima, Kuniyoshi Shimizu, Koichiro Ohnuki. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019 ;40(4):125-131. PMID: 31413233

[xxv] Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010 Aug;31(4):231-7. doi: 10.2220/biomedres.31.231. PMID: 20834180.

[xxvi] Farhan Asad, Haseeb Anwar, Hadi M Yassine, Muhammad Irfan Ullah, Aziz Rahman, Zahid Kamran, Muhammad Umar Sohail. White Button Mushroom, Agaricus bisporus (Agaricomycetes), and a Probiotics Mixture Supplementation Correct Dyslipidemia without Influencing the Colon Microbiome Profile in Hypercholesterolemic Rats. Int J Med Mushrooms. 2020 ;22(3):235-244. PMID: 32479018

K Khatun, H Mahtab, P A Khanam, M A Sayeed, K A Khan. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh Med J. 2007 Jan;16(1):94-9. PMID: 17344789

[xxvii] K Khatun, H Mahtab, P A Khanam, M A Sayeed, K A Khan. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh Med J. 2007 Jan;16(1):94-9. PMID: 17344789

[xxviii] Sijian Zheng, Shihao Deng, Yun Huang, Mi Huang, Ping Zhao, Xinhua Ma, Yanzhang Wen, Qiang Wang, Xinzhou Yang. Anti-diabetic activity of a polyphenol-rich extract from Phellinus igniarius in KK-Ay mice with spontaneous type 2 diabetes mellitus. Food Funct. 2018 Jan 24 ;9(1):614-623. PMID: 29271444

[xxix] Junling Yang, Huibin Dong, Ya Wang, Yun Jiang, Wenna Zhang, Yongming Lu, Yan Chen, Lei Chen. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis. Int J Biol Macromol. 2020 Nov 15 ;163:442-456. Epub 2020 Jun 24. PMID: 32592781

[xxx] Tao Jiang, Liang Wang, Angjie Ma, Yi Wu, Qiwen Wu, Qiulin Wu, Jianwei Lu, Tian Zhong. The hypoglycemic and renal protective effects of Grifola frondosa polysaccharides in early diabetic nephropathy. J Food Biochem. 2020 Oct 11:e13515. Epub 2020 Oct 11. PMID: 33043487

[xxxi] Thi Nhu Ngoc L, Oh YK, Lee YJ, Lee YC. Effects of Sparassis crispa in Medical Therapeutics: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Mol Sci. 2018 May 16;19(5):1487. doi: 10.3390/ijms19051487. PMID: 29772715; PMCID: PMC5983641.

Lyme Disease As a Reversible Cause of Chronic Illness For Some Patients

https://danielcameronmd.com/lyme-disease-cause-chronic-illnesses/

LYME DISEASE AS A REVERSIBLE CAUSE OF CHRONIC ILLNESS FOR SOME PATIENTS

lyme-disease-cause-chronic-illness

As the number of individuals with chronic illnesses continues to rise, clinicians and patients are looking for reversible causes to chronic symptoms that are often debilitating to patients. Reversible causes have included dementia, [1] coma, [2] complex arrhythmia, [3] and autoimmune encephalitis. [4]

Studies indicated that Lyme disease can lead to chronic disease including Lyme encephalopathy, [5] Lyme neuropathy, [6] chronic neurologic Lyme disease, [6] and Neuropsychiatric Lyme disease. [7]

Could Lyme disease be a reversible cause of other chronic illnesses in some patients? Having a high index of suspicion will prevent missing the diagnosis.

Following are dozens of published papers, described in an Inside Lyme Blog series, which features cases in which Lyme disease was a reversible cause of other chronic medical conditions. [8]

Brain Diseases and Neurological Disorders

80-year-old with Lyme encephalopathy instead of dementia
Chronic post-concussion syndrome symptoms due to Lyme disease
POTS patients with brain fog have neurocognitive deficits
When it looks like a brain tumor, but it is Lyme disease
Untreated Lyme disease triggers a stroke in 9-year-old boy
Lyme podcast: man with Lyme disease and stroke
Child with Lyme disease presenting as pseudotumor cerebri
Chronic inflammatory demyelinating polyneuropathy (CIDP) case resolved with antibiotics
Lyme meningitis, manifesting as parkinsonism, is fully reversed with ceftriaxone
Seizures and altered mental status after a tick bite
Dementia and normal pressure Hydrocephalus
Cognitive issues following a stroke due to Lyme disease
Stroke as a manifestation of Lyme disease
Lyme disease causes ‘false brain tumor’ in young child

Cardiac Disease

Broad range of presentations for Lyme carditis cases
Lyme carditis presenting as atrial fibrillation treated successfully
First report of Lyme disease causing mitral valve endocarditis
Lyme endocarditis in 68-year-old avid outdoorsman
Another cardiac manifestation of Lyme myocarditis
When Lyme disease mimics a heart attack
Physician-turned-patient becomes Lyme advocate – required a heart transplant

Autonomic Disorders

POTS: an autonomic disorder in Lyme disease patients
Subacute transverse myelitis caused by Borrelia infection
Femoral neuropathy as a neurologic symptom of Lyme disease
Autonomic dysfunction, small fiber neuropathy and Lyme disease
Acute transverse myelitis in a 25-year-old man with Lyme disease

Sleep Disorders

Lyme disease is associated with various sleep disorders

Psychiatric Illnesses

16-year-old boy with Lyme disease presenting as depression
Don’ t confuse somatic symptoms with depression in early Lyme disease
Oppositional behavior in children with Lyme disease
Can Lyme disease trigger obsessive compulsive symptoms?
Depression common in Lyme disease patients
Suicidal behaviors in patients with Lyme and associated diseases
7-year-old girl with Lyme disease presenting as attention deficit disorder
Treatment options for an anxious, suicidal patient with a history of Lyme disease

Movement Disorders

Subacute Parkinsonism as a complication of Lyme disease

Auditory Problems

Study finds hearing loss and tinnitus common in patients with tick-borne diseases
Lyme disease patient with permanent tinnitus and hearing loss

Autoimmune/Immune System Disorders

Lyme podcast: Sjögren’s syndrome secondary to Lyme disease
Can Lyme disease trigger an autoimmune disease? – Adult-onset Still’s disease (AOSD)
Lyme disease mimics autoimmune disorder in elderly woman – dermatomyositis
Could Lyme disease be another infection associated with the onset of Guillain-Barre syndrome?
PANDAS and Lyme disease in a 7-year-old child

Dermatological Conditions

6-year-old girl with a rare cutaneous presentation of Lyme disease – areolar lymphocytomainvolving her breast
Lyme disease mimics cellulitis skin infection
Lyme disease misdiagnosed as shingles in 62-year-old man

Sensory Impairments

What is that smell?

Eye or Ocular Disorders

Study looks at uveitis due to Lyme disease
69-year-old man with Lyme disease and double vision
Visual changes due to Lyme disease
Growing list of eye problems in Lyme disease
Lyme disease causes vision loss in 46-year-old woman

Inflammatory Disease

Can Lyme disease trigger sarcoidosis?

Joint Infections

Lyme disease mimics prosthetic joint infection following knee replacement

Gastrointestinal Illnesses

Neurologic Lyme disease presenting as abdominal pain in 71-year-old patient
Lyme disease manifests as abdominal pain in young child

 Kidney Disease

Doctors recognize Lyme disease in a patient with kidney disease
Kidney failure and disseminated rashes associated with Lyme disease


Conclusion: Substantial variability exists in the presenting features and clinical course of patients with Lyme disease. A diagnosis depends upon a thorough clinical evaluation, physical and neurologic examinations, along with laboratory testing. An accurate diagnosis and proper treatment can improve the outcome of patients with reversible causes of chronic symptoms.

References:
  1. Bello VME, Schultz RR. Prevalence of treatable and reversible dementias: A study in a dementia outpatient clinic. Dement Neuropsychol. Jan-Mar 2011;5(1):44-47. doi:10.1590/S1980-57642011DN05010008
  2. Edlow JA, Rabinstein A, Traub SJ, Wijdicks EF. Diagnosis of reversible causes of coma. Lancet. Dec 6 2014;384(9959):2064-76. doi:10.1016/S0140-6736(13)62184-4
  3. Pozzolini A, Rio T, Padeletti M, De Ponti R, Leonelli FM, Bagliani G. Complex Arrhythmias Due to Reversible Causes. Card Electrophysiol Clin. Jun 2019;11(2):375-390. doi:10.1016/j.ccep.2019.03.002
  4. Pandit AK, Ihtisham K, Garg A, Gulati S, Padma MV, Tripathi M. Autoimmune encephalitis: A potentially reversible cause of status epilepticus, epilepsy, and cognitive decline. Ann Indian Acad Neurol. Oct 2013;16(4):577-84. doi:10.4103/0972-2327.120476
  5. Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis. Aug 1999;180(2):377-83. doi:10.1086/314860
  6. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. Nov 22 1990;323(21):1438-44. doi:10.1056/NEJM199011223232102
  7. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. Nov 1994;151(11):1571-83. doi:10.1176/ajp.151.11.1571
  8. Inside Lyme Science blog. https://danielcameronmd.com/daniel-cameron-md-lyme-blog/ Last accessed 12/19/20.

Ticks Carrying Disease Found to Be Abundant in Beach Areas, Similar to Woodlands, According to New Study

https://www.bayarealyme.org/blog/ticks-carrying-disease-found-to-be-abundant-in-beach-areas-similar-to-woodlands-according-to-new-study/

TICKS CARRYING DISEASE FOUND TO BE ABUNDANT IN BEACH AREAS, SIMILAR TO WOODLANDS, ACCORDING TO NEW STUDY

Ticks Carrying Disease Found to Be Abundant in Beach Areas
 

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Ticks Carrying Disease Found to Be Abundant in Beach Areas, Similar to Woodlands, According to New Study

Study Funded by Bay Area Lyme Foundation Also Shows Ticks in Northern California Carry a Diversity of Disease-causing Bacteria at Higher Rates Than Previously Reported

Portola Valley, CA, April 23, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a study demonstrating that adult Western black-legged ticks (Ixodes pacificus) carrying Borrelia burgdorferi, the bacterium that causes Lyme disease, were found in beach areas at equal rates to the woodland habitats in parts of northwestern California. Further, researchers, who were testing ticks for up to 5 species of tick-borne bacteria, found that the collective infection rate of all species was as high as 31% in at least one area, which offers a different perspective from previous studies that tested for a single species of bacteria in a specific area or areas. Conducted by researchers at Colorado State University, Northern Arizona State University and Translational Genomics Research Institute (TGen), and published in the June issue of the peer-reviewed journal Applied and Environmental Microbiology (AEM), the research points to the need for greater education for both the community at large and healthcare providers about the risks of tick-borne disease.

“The high rate of disease-carrying ticks in the coastal chaparral was really surprising to us. And when looking at all the tick-borne pathogens simultaneously, it makes you rethink the local disease risk,” said Lead Author Daniel Salkeld, PhD, Colorado State University. “Previously, we, along with other researchers, may have missed the big picture when we focused our attention on investigating the risk of one pathogen at a time. Now, we have a new imperative to look at the collective risk of all tick-borne pathogens in an area.”

Researchers sought to quantify the prevalence of five species of bacteria—Borrelia burgdorferi, Borrelia americana, Borrelia bissettiae, Borrelia miyamotoi and Anaplasma phagocytophilum—in Western black-legged ticks (I. pacificus) across multiple habitats. Habitats included woodlands and grasslands as well as coastal chaparral, which is a habitat that has not previously been studied. Ticks may also carry viruses and parasites, however only bacteria were included in this study.

“Beaches and lizard habitats can no longer be considered havens from ticks. Based on this new data, we are now encouraging residents to take preventative measures in beach areas and encouraging healthcare providers to learn the symptoms of tick-borne infections beyond Lyme disease,” said Linda Giampa, executive director at Bay Area Lyme Foundation. “Prevention of tick-borne disease is critical and ecology studies like this highlight the need to be vigilant anytime we are in the outdoors.”

This was the first study to characterize bacteria carried by ticks in the chaparral in beach areas. Coastal chaparral is a natural habitat for fence lizards, which have previously been found to carry a blood protein that kills Borrelia bacteria, although studies over the past 20 years have offered differing results.

Authors note that more research is necessary to better understand which animals may be hosts for the ticks in beach areas. It is speculated that the hosts may be rabbits, voles and/or the white-footed mouse. The grey squirrel, which has been known to be the primary tick host in northwestern California, doesn’t live in coastal areas. Additionally, the prevalence and role of the fence lizard should be further explored.

More information about preventing tick bites can be found here, and here is the link to the study: https://doi.org/10.1128/AEM.00319-21

About the Study
Researchers conducted tick drags of public and private areas including California State Parks (SP), County and Regional Parks, and National Parks in in Marin, Mendocino, Monterey, Napa, Santa Clara, Santa Cruz and Sonoma Counties.

Aggregated across all sites, prevalence of Borrelia burgdorferi sensu lato alone was 2.9% (95% CI = 2.3-3.7%), and Borrelia miyamotoi in adult ticks occurred at a lower prevalence than B. burgdorferi sensu lato: 1.3% (95% CI = 0.8-1.8%). However, prevalence of B. miyamotoi in nymphal ticks reached as high as 17.8% (95% CI = 10.5-27.3, n = 90) in some areas. Presence of Anaplasma phagocytophilum was sporadic throughout the area with highest rates observed up to 7.8% (95% CI = 3.2-15.4%.).

About Tick-borne Disease
The CDC recognizes 15 tick-borne diseases, and there are at least 9 different types of ticks that carry these diseases. Tick-borne disease has been diagnosed in every state in the country. The most common vector-borne infectious disease in the country, Lyme disease is a potentially disabling infection caused by the Borrelia burgdorferi bacteria. If caught early, most cases of Lyme disease can be effectively treated, but it is commonly misdiagnosed due to lack of awareness and unreliable diagnostic tests. According to the CDC, there are nearly 500,000 new cases of Lyme disease each year. As a result of the difficulty in diagnosing and treating Lyme disease, more than one million Americans may be suffering from the impact of its debilitating long-term symptoms and complications, according to Bay Area Lyme Foundation estimates.

About Bay Area Lyme Foundation
Bay Area Lyme Foundation, a national organization committed to making Lyme disease easy to diagnose and simple to cure, is the leading public not-for-profit sponsor of innovative Lyme disease research in the US. A 501c3 non-profit organization based in Silicon Valley, Bay Area Lyme Foundation collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease. It is also dedicated to providing reliable, fact-based information so that prevention and the importance of early treatment are common knowledge. A pivotal donation from The LaureL STEM Fund covers overhead costs and allows for 100% of all donor contributions to Bay Area Lyme Foundation to go directly to research and prevention programs. For more information about Lyme disease or to get involved, visit www.bayarealyme.org or call us at 650-530-2439.

# # #

Media contact:
Tara DiMilia
Phone: 908-369-7168
Tara.DiMilia@tmstrat.com

________________________

For More:

Humans Infested with Ixodes Ricinus Are Exposed to a Diverse Array of Tick-borne Pathogens in Serbia

https://www.sciencedirect.com/science/article/abs/pii/S1877959X20304799

Humans infested with Ixodes ricinus are exposed to a diverse array of tick-borne pathogens in Serbia

Abstract

Tick-borne pathogens (TBPs) pose a major threat to human health in Europe and the whole northern hemisphere. Despite a high prevalence of TBPs in Ixodes ricinus ticks, knowledge on the incidence of tick-borne diseases in humans infested by this tick species is limited. This study was conducted in the year 2019 on patients who presented themselves to the Pasteur Institute Novi Sad with tick infestations. Ticks (n = 31) feeding on human (n = 30) and blood samples from the same individuals were collected by physicians and a microfluidic real-time high-throughput PCR system was used to test the genomic DNA of the samples for the presence of 27 bacterial and eight parasitic microorganisms in Serbia. Except for one Rhipicephalus sanguineus s.l. adult male tick, all ticks infesting humans were morphologically identified as I. ricinus.

  • A high proportion of ticks (74%, 23/31) were infected with at least one of the tested TB microorganisms, being Rickettsia helvetica (54 %, 17/31) the most common pathogen, but
  • Borrelia afzelii (9 %, 3/31),
  • Anaplasma phagocytophilum (6 %, 2/31),
  • Borrelia miyamotoi (6 %, 2/31), and
  • Francisella like-endosymbiont (6 %, 2/31),
  • Borrelia valaisiana (3 %, 1/31),
  • Borrelia lusitaniae (3 %, 1/31),
  • Rickettsia felis (3 %, 1/31) and
  • Rickettsia aeschlimannii (3 %, 1/31) were also identified.

Despite the high infection rate of TBPs in ticks, only two human blood samples (6 %, 2/30) tested positive for the presence of TBPs, one patient (code H12, 67 years old female) was diagnosed with Borrelia spp. and the other patient was diagnosed (code H17, 71 years old female) with R. felis infection. The tick infesting patient H12 tested positive for B. afzelii, and R. helvetica and the tick infesting patient H17 tested positive for R. felis. Upon clinical examination, both patients were diagnosed with erythema migrans. No additional discomfort was reported by the patient and no additional pathology was observed by the physician. We concluded that humans bitten by I. ricinus in Serbia are exposed to a diverse array of TBPs with clinical impact in the Serbian cohort studied.